南方医科大学学报
南方醫科大學學報
남방의과대학학보
JOURNAL OF SOUTHERN MEDICAL UNIVERSITY
2013年
10期
1525-1528
,共4页
于长辉%黄纯炽%毛华%余建林
于長輝%黃純熾%毛華%餘建林
우장휘%황순치%모화%여건림
肝硬化%部分脾动脉栓塞术%脾栓术后综合征%糖皮质激素
肝硬化%部分脾動脈栓塞術%脾栓術後綜閤徵%糖皮質激素
간경화%부분비동맥전새술%비전술후종합정%당피질격소
cirrhosis%partial splenic embolization%partial splenic embolization syndrome%glucocorticoids
目的分析、对比脾栓术后综合征使用糖皮质激素或解热镇痛药的临床效果。方法选择肝硬化合并脾功能亢进术后出现脾栓术后综合征的患者共60例,所有患者均采用Seldinger技术进行部分脾动脉栓塞术。观察组30例患者术后应用地塞米松静脉注射,对照组患者口服非甾体类解热镇痛药。脾栓术后7d观察外周血白细胞、肝功能、血白蛋白。同时还观察发热时间、腹痛时间、住院天数及是否出现上消化道出血、脾脓肿等并发症。结果观察组患者发热时间3.36±2.31 d,疼痛时间7.39±4.00 d,住院天数11.48±3.29 d,对照组发热时间5.72±3.83 d,疼痛时间9.59±4.22 d,住院天数15.07±7.93 d,观察组明显好于对照组(P<0.05)。脾栓术后7天,两组患者白细胞均较术前升高,观察组由(4.23±5.09)×109/L升至(8.49±3.53)×109/L(P<0.05),对照组由(3.21±1.33)×109/L升至(6.52±2.37)×109/L(P<0.05),但观察组术后白细胞较对照组术后白细胞升高更明显(P<0.05)。在肝功能方面(胆红素、谷丙转氨酶、谷草转氨酶、血清白蛋白)两组术前术后均无明显变化。两组均未出现上消化道出血和脾脓肿的并发症。结论脾栓术后综合征静脉应用糖皮质激素效果优于口服解热镇痛药。
目的分析、對比脾栓術後綜閤徵使用糖皮質激素或解熱鎮痛藥的臨床效果。方法選擇肝硬化閤併脾功能亢進術後齣現脾栓術後綜閤徵的患者共60例,所有患者均採用Seldinger技術進行部分脾動脈栓塞術。觀察組30例患者術後應用地塞米鬆靜脈註射,對照組患者口服非甾體類解熱鎮痛藥。脾栓術後7d觀察外週血白細胞、肝功能、血白蛋白。同時還觀察髮熱時間、腹痛時間、住院天數及是否齣現上消化道齣血、脾膿腫等併髮癥。結果觀察組患者髮熱時間3.36±2.31 d,疼痛時間7.39±4.00 d,住院天數11.48±3.29 d,對照組髮熱時間5.72±3.83 d,疼痛時間9.59±4.22 d,住院天數15.07±7.93 d,觀察組明顯好于對照組(P<0.05)。脾栓術後7天,兩組患者白細胞均較術前升高,觀察組由(4.23±5.09)×109/L升至(8.49±3.53)×109/L(P<0.05),對照組由(3.21±1.33)×109/L升至(6.52±2.37)×109/L(P<0.05),但觀察組術後白細胞較對照組術後白細胞升高更明顯(P<0.05)。在肝功能方麵(膽紅素、穀丙轉氨酶、穀草轉氨酶、血清白蛋白)兩組術前術後均無明顯變化。兩組均未齣現上消化道齣血和脾膿腫的併髮癥。結論脾栓術後綜閤徵靜脈應用糖皮質激素效果優于口服解熱鎮痛藥。
목적분석、대비비전술후종합정사용당피질격소혹해열진통약적림상효과。방법선택간경화합병비공능항진술후출현비전술후종합정적환자공60례,소유환자균채용Seldinger기술진행부분비동맥전새술。관찰조30례환자술후응용지새미송정맥주사,대조조환자구복비치체류해열진통약。비전술후7d관찰외주혈백세포、간공능、혈백단백。동시환관찰발열시간、복통시간、주원천수급시부출현상소화도출혈、비농종등병발증。결과관찰조환자발열시간3.36±2.31 d,동통시간7.39±4.00 d,주원천수11.48±3.29 d,대조조발열시간5.72±3.83 d,동통시간9.59±4.22 d,주원천수15.07±7.93 d,관찰조명현호우대조조(P<0.05)。비전술후7천,량조환자백세포균교술전승고,관찰조유(4.23±5.09)×109/L승지(8.49±3.53)×109/L(P<0.05),대조조유(3.21±1.33)×109/L승지(6.52±2.37)×109/L(P<0.05),단관찰조술후백세포교대조조술후백세포승고경명현(P<0.05)。재간공능방면(담홍소、곡병전안매、곡초전안매、혈청백단백)량조술전술후균무명현변화。량조균미출현상소화도출혈화비농종적병발증。결론비전술후종합정정맥응용당피질격소효과우우구복해열진통약。
Objective To compare the clinical effect of glucocorticoids and NSAID in the treatment of partial splenic embolization syndrome. Methods Sixty patients with cirrhosis and spleen hyperactivity who developed partial splenic embolization syndrome after partial splenic embolization with Seldinger technique were randomized equally into two groups to receive treatments with intravenous dexamethasone or oral nonsteroidal anti-inflammatory drugs (NSAIDs). White blood cell counts, liver functions, fever duration, abdominal pain duration, hospital stay, and occurrence of upper gastrointestinal hemorrhage and spleen abscess were recorded and analyzed. Results In dexamethasone group, the average fever duration, abdominal pain duration, and hospitalization days was 3.36 ± 2.31, 7.39 ± 4.00, and 11.48 ± 3.29 days, respectively, significantly shorter than those in NSAIDs group (5.72 ± 3.83, 9.59 ± 4.22, and 15.07 ± 7.93 days, respectively, P<0.05). Seven days after the operation, white blood cell count (×109/L) significantly increased from 4.23±5.09 to 8.49±3.53 in dexamethasone group (P<0.05), and from 3.21±1.33 to 6.52±2.37 in NSAIDs group (P<0.05);the increment was more obvious in dexamethasone group (P<0.05). The two groups of patients showed no significant difference in liver functions after the operation. None of the patients developed upper gastrointestinal hemorrhage or spleen abscess. Conclusion Intravenous dexamethasone produces better therapeutic effect than oral NSAIDs in the management of partial splenic embolization syndrome.